Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MabThera + Chemotherapy in Untreated Mantle Cell Lymphoma
NCT00472420Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2007
- Primary completion
- May 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rituximab in mantle cell lymphoma (MCL), sponsored by Roche. Primary endpoint: Number of Participants Achieving Complete Remission (CR) or Partial Remission (PR). Started Jun 2007; status: completed.
02
Drugs
rituximab
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT00472420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00472420.